Cost-utility of a new psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family) versus goal-setting and routine care: economic evaluation embedded within a randomised controlled trial.

Abdinasir Isaaq, Claudia Cooper, Victoria Vickerstaff, Julie Barber, Kate Walters, Iain Lang, Penny Rapaport, Vasiliki Orgeta, Kenneth Rockwood, Laurie Butler, Kathryn Lord, Gill Livingston, Sube Banerjee, Jill Manthorpe, Helen Kales, Jessica Budgett, Rachael M Hunter
{"title":"Cost-utility of a new psychosocial goal-setting and manualised support intervention for Independence in Dementia (NIDUS-Family) versus goal-setting and routine care: economic evaluation embedded within a randomised controlled trial.","authors":"Abdinasir Isaaq, Claudia Cooper, Victoria Vickerstaff, Julie Barber, Kate Walters, Iain Lang, Penny Rapaport, Vasiliki Orgeta, Kenneth Rockwood, Laurie Butler, Kathryn Lord, Gill Livingston, Sube Banerjee, Jill Manthorpe, Helen Kales, Jessica Budgett, Rachael M Hunter","doi":"10.1101/2024.08.24.24312530","DOIUrl":null,"url":null,"abstract":"Background: NIDUS-Family is a 6-8 session, psychosocial and behavioural intervention, delivered by non-clinical facilitators, tailored to goals set by dementia-unpaid/family carer dyads. It is effective in terms of attainment of personalised client goals. We aimed to determine if it is cost-effective. Methods: This cost utility and cost-effectiveness analysis is within a two-armed, single masked, multi-site, superiority Randomised Controlled Trial (RCT). We recruited 302 dyads from community settings. Randomisation was blocked and site-stratified, using a 2:1 ratio (intervention: control (goal-setting and routine care)), with allocation by remote web-based system. We calculated the probability that NIDUS-Family is cost-effective for a client with dementia based on Quality Adjusted Life Year (QALY) from health and personal social services and societal perspectives, at GBP 20,000-30,000 decision thresholds for QALY gained, compared to usual care over 12 months. Analyses were intention-to-treat. Trial registration: ISRCTN11425138. Findings: From 30.4.2020-9.5.2022, 204 participants (109 (53.4%) female) were randomised to intervention and 98 (60 (61.2%) female) to control. 218 (72.2%) participants at 6 months and 178 (58.9%) at 12 months provided cost data. There was 89% and 87% probability that NIDUS-Family was cost-effective compared to usual care from personal social services and societal perspectives respectively. Intervention participants accrued on average GBP 8934 (37%) less costs than control participants (95% CI -59,460 to 41,592). Interpretation: NIDUS-Family is the first personalised care and support intervention to demonstrate cost-effectiveness from the perspective of the quality of life of people with dementia, as well as clinical effectiveness and should be part of routine dementia care.","PeriodicalId":501072,"journal":{"name":"medRxiv - Health Economics","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Health Economics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.24.24312530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: NIDUS-Family is a 6-8 session, psychosocial and behavioural intervention, delivered by non-clinical facilitators, tailored to goals set by dementia-unpaid/family carer dyads. It is effective in terms of attainment of personalised client goals. We aimed to determine if it is cost-effective. Methods: This cost utility and cost-effectiveness analysis is within a two-armed, single masked, multi-site, superiority Randomised Controlled Trial (RCT). We recruited 302 dyads from community settings. Randomisation was blocked and site-stratified, using a 2:1 ratio (intervention: control (goal-setting and routine care)), with allocation by remote web-based system. We calculated the probability that NIDUS-Family is cost-effective for a client with dementia based on Quality Adjusted Life Year (QALY) from health and personal social services and societal perspectives, at GBP 20,000-30,000 decision thresholds for QALY gained, compared to usual care over 12 months. Analyses were intention-to-treat. Trial registration: ISRCTN11425138. Findings: From 30.4.2020-9.5.2022, 204 participants (109 (53.4%) female) were randomised to intervention and 98 (60 (61.2%) female) to control. 218 (72.2%) participants at 6 months and 178 (58.9%) at 12 months provided cost data. There was 89% and 87% probability that NIDUS-Family was cost-effective compared to usual care from personal social services and societal perspectives respectively. Intervention participants accrued on average GBP 8934 (37%) less costs than control participants (95% CI -59,460 to 41,592). Interpretation: NIDUS-Family is the first personalised care and support intervention to demonstrate cost-effectiveness from the perspective of the quality of life of people with dementia, as well as clinical effectiveness and should be part of routine dementia care.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痴呆症患者自立能力的新型心理社会目标设定和手动支持干预(NIDUS-Family)与目标设定和常规护理的成本效益对比:随机对照试验中的经济评估。
背景:NIDUS-Family 是一项为期 6-8 个疗程的社会心理和行为干预措施,由非临床促进者根据痴呆-无偿/家庭照护者二元组合设定的目标提供。从实现客户个性化目标的角度来看,该干预措施非常有效。我们的目标是确定它是否具有成本效益。方法:这项成本效用和成本效益分析是在一项双臂、单人、多地点、优越性随机对照试验(RCT)中进行的。我们从社区环境中招募了 302 对夫妇。随机分配采用阻断和地点分层方式,比例为 2:1(干预:对照(目标设定和常规护理)),并通过远程网络系统进行分配。我们从健康、个人社会服务和社会角度出发,按照获得 QALY 的 20,000-30,000 英镑决策阈值,计算了 NIDUS-Family 在 12 个月内与常规护理相比,对痴呆症患者而言具有成本效益的概率。分析方法为意向治疗。试验注册:ISRCTN11425138。研究结果:从 2020 年 4 月 30 日至 2022 年 5 月 9 日,204 名参与者(109 人(53.4%)为女性)被随机分配到干预组,98 人(60 人(61.2%)为女性)被随机分配到对照组。218 名参与者(72.2%)提供了 6 个月的成本数据,178 名参与者(58.9%)提供了 12 个月的成本数据。从个人社会服务和社会角度来看,"NIDUS-家庭 "与常规护理相比,分别有89%和87%的可能性具有成本效益。干预参与者的费用比对照参与者平均少 8934 英镑(37%)(95% CI -59460-41592)。解释:NIDUS-Family是首个从痴呆症患者的生活质量和临床效果角度证明具有成本效益的个性化护理和支持干预措施,应该成为常规痴呆症护理的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Co-developing a comprehensive disease policy model with stakeholders: the case of malaria during pregnancy How does participation in coal-to-gas policy and availability of natural gas pipelines affect residents' well-being? Causally-informative analyses of the effect of job displacement on all-cause and specific-cause mortality from the 1990s Finnish recession until 2020: A population registry study Privacy Protection of Sexually Transmitted Infections Information from Chinese Electronic Medical Records Quantifying the health impact of crop breeding: Revisiting the Disability-Adjusted Life Years Approach
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1